オオモリ テツペイ
Oomori Tetsupei
大森 鉄平 所属 医学部 医学科(東京女子医科大学病院) 職種 非常勤講師 |
|
論文種別 | 原著 |
言語種別 | 英語 |
査読の有無 | 査読なし |
表題 | Nationwide multicenter study on adverse events associated with a patency capsule: Additional survey of appropriate use of patency capsule study |
掲載誌名 | 正式名:Journal of gastroenterology and hepatology 略 称:J Gastroenterol Hepatol ISSNコード:14401746/08159319 |
掲載区分 | 国外 |
巻・号・頁 | 39(2),pp.337-345 |
著者・共著者 | OMORI Teppei,OHMIYA Naoki,WATANABE Kenji,HIRAI Fumihito,NAKAMURA Masanao,KITAMURA Kazuya,OZEKI Keiji,OKA Shiro,KAWANO Seiji,HANDA Osamu,KAWAI Mikio,NINOMIYA Kazeo,SAGAWA Tamotsu,WAKAMATSU Takahiro,ARAI Akihiro,KOIKE Yuji,KATO Shingo,HASHIMOTO Shinichi,MANNAMI Tomohiko,NAKAJI Konosuke,TANAKA Shinji,MATSUI Toshiyuki |
担当区分 | 筆頭著者 |
発行年月 | 2024/02 |
概要 | BACKGROUND AND AIM:The PillCam patency capsule (PC) without a radio frequency identification tag was released to preclude retention of the small bowel capsule endoscope (CE) in Japan in 2012. We conducted a multicenter study to determine tag-less PC-related adverse events (AEs).METHODS:We first conducted a retrospective survey using a standardized data collection sheet for the clinical characteristics of PC-related AEs among 1096 patients collected in a prospective survey conducted between January 2013 and May 2014 (Cohort 1). Next, we retrospectively investigated additional AEs that occurred before and after Cohort 1 within the period June 2012 and December 2014 among 1482 patients (Cohort 2).RESULTS:Of the 2578 patients who underwent PC examinations from both cohorts, 74 AEs occurred among 61 patients (2.37%). The main AEs were residual parylene coating in 25 events (0.97%), PC-induced small bowel obstruction, suspicious of impaction, in 23 events (0.89%), and CE retention even after patency confirmation in 10 events (0.39%). Residual parylene coating was significantly associated with Crohn's disease (P < 0.01). Small bowel obstruction was significantly associated with physicians with less than 1 year of experience handling the PC and previous history of postprandial abdominal pain (P < 0.01 and P < 0.03, respectively). CE retention was ascribed to erroneous judgment of PC localization in all cases.CONCLUSIONS:This large-scale multicenter study provides evidence supporting the safety and efficiency of a PC to preclude CE retention. Accurate PC localization in patients without excretion and confirmation of previous history of postprandial abdominal pain before PC examinations is warranted (UMIN000010513). |
DOI | 10.1111/jgh.16365 |
PMID | 37842961 |